Cassava Sciences, Inc.
SAVA
|
$20.48
-3.35%
250K
|
Health Technology
(0.0% 1d) (-3.2% 1m) (-9.0% 1y) (0.0% 2d) (0.0% 3d) (6.3% 7d) (-49.0% volume)
Earnings Calendar: 2024-02-28
Market Cap: $ 885,673,124
http://www.cassavasciences.com
Sec Filling | Patents | 9 employees
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.
alzheimer diagnostics treatment alzheimer’s
add to watch list Paper trade email alert is off
Press-releases
Redemption Date Announced for Warrants
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
SAVA | $20.48 -3.35% 250K
|
Health Technology
|
| O: 0.13%
H: 0.66%
C: -12.16%
redemption for
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages The Chemours Company Investors to Secure Counsel Before Important Deadline in Securities Class Action - CC
Published: 2024-03-27 (Crawled : 21:00) - prnewswire.com
JBSAY | $8.435 100K
|
n/a
|
| O: -0.98%
H: 0.69%
C: -2.52%
CC | $26.31 -0.64% 120K
|
Process Industries
|
| O: -13.43%
H: 9.6%
C: 5.04%
SAVA | $20.48 -3.35% 250K
|
Health Technology
|
| O: -0.78%
H: 2.07%
C: 0.15%
company deadline
Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
Published: 2024-03-25 (Crawled : 13:00) - globenewswire.com
SAVA | $20.48 -3.35% 250K
|
Health Technology
|
| O: 3.43%
H: 2.0%
C: -3.86%
review trials sciences
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMLX
Published: 2024-03-20 (Crawled : 00:00) - prnewswire.com
AMLX | $1.985 0.25% 270K
|
|
| O: 2.02%
H: 0.0%
C: -5.28%
INVZ | News | $1.05 -0.94% 460K
|
|
| O: 2.92%
H: 1.77%
C: 1.42%
SAVA | $20.48 -3.35% 250K
|
Health Technology
|
| O: 0.18%
H: 0.64%
C: -3.77%
deadline
ROSEN, A LONGSTANDING LAW FIRM, Encourages Innoviz Technologies Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INVZ, INVZW
Published: 2024-03-20 (Crawled : 23:00) - prnewswire.com
INVZ | News | $1.05 -0.94% 460K
|
|
| O: 2.92%
H: 1.77%
C: 1.42%
SAVA | $20.48 -3.35% 250K
|
Health Technology
|
| O: 0.18%
H: 0.64%
C: -3.77%
BROG | $1.15 3.6% 540K
|
Finance
|
| O: -2.04%
H: 0.0%
C: -0.35%
deadline
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
Published: 2024-03-20 (Crawled : 23:00) - prnewswire.com
ADM | $62.66 1.52% 770K
|
Process Industries
|
| O: 0.33%
H: 2.4%
C: 1.56%
SAVA | $20.48 -3.35% 250K
|
Health Technology
|
| O: 0.18%
H: 0.64%
C: -3.77%
BROG | $1.15 3.6% 540K
|
Finance
|
| O: -2.04%
H: 0.0%
C: -0.35%
deadline
ROSEN, A LEADING LAW FIRM, Encourages Xponential Fitness, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - XPOF
Published: 2024-03-05 (Crawled : 13:00) - prnewswire.com
XPOF | $13.3 1.45% 120K
|
|
| O: 1.85%
H: 7.51%
C: 2.66%
CMI | $290.25 -0.4% 210K
|
Producer Manufacturing
|
| O: -0.25%
H: 1.76%
C: 0.27%
SAVA | $20.48 -3.35% 250K
|
Health Technology
|
| O: -0.49%
H: 0.45%
C: -4.42%
deadline
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
Published: 2024-03-04 (Crawled : 20:00) - prnewswire.com
CMI | $290.25 -0.4% 210K
|
Producer Manufacturing
|
| O: -0.25%
H: 1.76%
C: 0.27%
SAVA | $20.48 -3.35% 250K
|
Health Technology
|
| O: -0.49%
H: 0.45%
C: -4.42%
RILY | $19.7 -0.25% 71K
|
Finance
|
| O: -2.88%
H: 13.58%
C: 3.95%
deadline
Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conference
Published: 2024-03-04 (Crawled : 14:00) - globenewswire.com
SAVA | $20.48 -3.35% 250K
|
Health Technology
|
| O: 0.13%
H: 0.69%
C: -2.26%
conference presentation international sciences
Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates
Published: 2024-02-28 (Crawled : 14:00) - globenewswire.com
SAVA | $20.48 -3.35% 250K
|
Health Technology
|
| O: 0.43%
H: 9.87%
C: -0.74%
sciences financial results
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 79% | 21% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
ZCMD | $1.98 36.55% 27M
|
Commercial Services
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
AULT | $0.304 25.57% 47M
|
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
Last 48 Hours Insiders Buying
CLSD | $1.42 7.58% 100K
|
Health Technology
|
14:00
CDZI P 25000 | $2.275 1.11% 74K
|
Utilities
|
14:00
ETST P 39000 | $0.068 43K
|
Manufacturing
|
13:30
FNLC P 1275 | $22.47 1.4% 6.6K
|
Finance
|
12:30
ADMQ | $0.0532 480K
|
|
10:30
AXR P 2400 | $22.26 0.41% 180
|
Finance
|
21:00
QCRH P 118 | $56.105 1.25% 11K
|
Finance
|
18:01
VUZI P 7500 | $1.245 -1.19% 140K
|
Electronic Technology
|
18:00
RMCF | $3.5501 390
|
Consumer Non-Durables
|
20:10